Fig. 2From: Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarctionPrescriptions of MRA, beta-blockers, and ACE-inhibitors or ARBs in patients meeting criteria for MRA usage between study periods. MRA mineralocorticoid receptor antagonist, ACE-i angiotensin converting enzyme inhibitor, ARB angiotensin receptor blockerBack to article page